Skip to content 
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -0.12% | -0.68% |
| 1-Month Return | 2.7% | -2.01% |
| 3-Month Return | 16.13% | 0.79% |
| 6-Month Return | 28.09% | 13.67% |
| 1-Year Return | 37.38% | 15.09% |
| 3-Year Return | 38.5% | 68.95% |
| 5-Year Return | -25.69% | 71.22% |
| 10-Year Return | 73.59% | 259.24% |
| Stock name | Ticker | Weight |
|---|---|---|
 GUARDANT HEALTH INC | GH | 9.37% |
 NATERA INC | NTRA | 8.71% |
 KRYSTAL BIOTECH INC | KRYS | 5.72% |
 LIGAND PHARMACEUTICALS | LGND | 4.48% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 4.38% |
 TWIST BIOSCIENCE CORP | TWST | 3.74% |
 TRAVERE THERAPEUTICS INC | TVTX | 3.32% |
 BRIDGEBIO PHARMA INC | BBIO | 3.31% |
 VERTEX PHARMACEUTICALS IN | VRTX | 2.77% |
 CORTEVA INC | CTVA | 2.69% |
 MEDPACE HOLDINGS INC | MEDP | 2.68% |
 UNITED THERAPEUTICS CORP | UTHR | 2.51% |
 ELI LILLY & CO | LLY | 2.35% |
 REGENERON PHARMACEUTICALS | REGN | 2.22% |
 REPLIGEN CORP | RGEN | 1.91% |
 ARGENX SE | ARGX.BR | 1.71% |
 TEMPUS AI INC-CL A | TEM | 1.67% |
 NEUROCRINE BIOSCIENCES IN | NBIX | 1.67% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 1.48% |
 CHARLES RIVER LABORATORIE | CRL | 1.48% |
 CAREDX INC | CDNA | 1.39% |
 PRAXIS PRECISION MEDICINE | PRAX | 1.26% |
 BIONTECH SE-ADR | BNTX | 1.23% |
 GRAIL INC | GRAL | 1.2% |
 PTC THERAPEUTICS INC | PTCT | 1.17% |
 STOKE THERAPEUTICS INC | STOK | 1.16% |
 INSMED INC | INSM | 1.13% |
 10X GENOMICS INC-CLASS A | TXG | 1.08% |
 IQVIA HOLDINGS INC | IQV | 1.08% |
 REVOLUTION MEDICINES INC | RVMD | 1.02% |
 ROYALTY PHARMA PLC- CL A | RPRX | 1.01% |
 KINIKSA PHARMACEUTICALS I | KNSA | 1% |
 VERACYTE INC | VCYT | 0.99% |
 SAMSUNG BIOLOGICS CO LTD | 207940.KS | 0.98% |
 CRISPR THERAPEUTICS AG | CRSP | 0.91% |
 THERMO FISHER SCIENTIFIC | TMO | 0.88% |
 HINGE HEALTH INC-A | HNGE | 0.86% |
 SARTORIUS AG-VORZUG | SRT3.DE | 0.84% |
 ANAPTYSBIO INC | ANAB | 0.82% |
 ETON PHARMACEUTICALS INC | ETON | 0.74% |
 AXSOME THERAPEUTICS INC | AXSM | 0.69% |
 BEAM THERAPEUTICS INC | BEAM | 0.64% |
 CADENCE DESIGN SYS INC | CDNS | 0.64% |
 FIRST TRACKS BIOTHERAPEUT | TRAX | 0.62% |
 AGILENT TECHNOLOGIES INC | A | 0.61% |
 ROIVANT SCIENCES LTD | ROIV | 0.55% |
 GENMAB A/S -SP ADR | GMAB | 0.54% |
 TG THERAPEUTICS INC | TGTX | 0.53% |
 MINERALYS THERAPEUTICS IN | MLYS | 0.52% |
 ASTRAZENECA PLC | AZN.L | 0.51% |
 QIAGEN N.V. | QIA.DE | 0.5% |
 GLAUKOS CORP | GKOS | 0.48% |
 MODERNA INC | MRNA | 0.46% |
 CELCUITY INC | CELC | 0.45% |
 COGENT BIOSCIENCES INC | COGT | 0.41% |
 VERADERMICS INC | MANE | 0.41% |
 RHYTHM PHARMACEUTICALS IN | RYTM | 0.37% |
 ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.36% |
 TARSUS PHARMACEUTICALS IN | TARS | 0.32% |
 BIO-RAD LABORATORIES-A | BIO | 0.31% |
 BEONE MEDICINES LTD-ADR | ONC | 0.27% |
 NEUROGENE INC | NGNE | 0.25% |
 LIQUIDIA CORP | LQDA | 0.21% |
 GENEDX HOLDINGS CORP | WGS | 0.17% |
 SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.15% |
 ULTRAGENYX PHARMACEUTICAL | RARE | 0.14% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
 Net Current Assets | Net.Current.Assets | -0.01% |
 CASH | CASH | -0.01% |
| Sector | Weight |
|---|---|
|
Health care | 96.71% |
|
Materials | 2.66% |
|
Information Technology | 0.63% |
Franklin Genomic Advancements ETF (HELX) share price today is $41.44.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $43.51. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $29.68.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied 
